Glycotope offers GMP-compliant contract manufacturing based on human and animal cell culture systems and perfusion fermentation technologies. We can use customers’ cell lines, or our own from the proprietary human GlycoExpress™ technology. This regulatory endorsed technology enables cost efficient production with high quality, outstanding productivity (up to 20 g/l fermenter volume in perfusion) and high batch-to-batch consistency of pharmaceutical proteins with optimized glycosylation pattern and antibodies.
Our manufacturing services are enhanced by extensive work in immunology, cell biology, molecular biology and protein chemistry.
Glycotope complies with all requirements of European Pharmaceutical legislation, the European Pharmacopoeia, and EU and ICH guidelines.